Journal
DIABETIC MEDICINE
Volume 29, Issue 7, Pages E1-E12Publisher
WILEY
DOI: 10.1111/j.1464-5491.2012.03617.x
Keywords
diabetes mellitus; mechanism; new onset; organ transplantation
Categories
Funding
- promotive research fund for excellent young and middle-aged scientists of Shandong Province [BS2009YY014]
Ask authors/readers for more resources
Diabet. Med. 29, e1e12 (2012) Abstract New-onset diabetes after transplantation is recognized as one of the metabolic consequences which may increase the risk of morbidity and mortality after solid organ transplantation. The pathophysiology of new-onset diabetes after transplantation has not been clearly defined and may resemble that of Type 2 diabetes, characterized by predominantly insulin resistance or defective insulin secretion, or both. This review aims to summarize the current state of knowledge regarding the prevalence, consequences, pathogenesis, and management of new-onset diabetes after transplantation, with a major focus on the possible mechanisms involved in the pathogenesis of the disorder. The aetiology of new-onset diabetes after transplantation is multifactorial, with diabetogenic immunosuppressive drugs playing a major role. Multiple cellular and physiologic mechanisms are involved in the process. Selection of an appropriate maintenance immunosuppressive regimen should involve balancing the risk of patient and graft survival vs. the potential for new-onset diabetes after transplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available